Abstract
The FDA recently reclassified indoor tanning devices that emit ultraviolet (UV) radiation from low risk (class I) to moderate risk (class II). This action was prompted primarily by data showing that indoor tanning bed use is linked to both melanoma and nonmelanoma skin cancers. Tanning bed use can also result in acute adverse effects, but little information has been published on such incidence. In …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have